Abbott Laboratories
ABT
Κατάταξη σε μετοχές
#103
Abbott Laboratories, along with its affiliated entities, is a global healthcare... Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.
Τιμή μετοχής
$104.70
Τελευταίος συγχρονισμός: 2026-10-16
Κεφαλαιοποίηση
$181.16B
Αλλαγή (1 ημέρα)
-0.09%
Αλλαγή (1 έτος)
-18.26%
Χώρα
US
Εμπόριο Abbott Laboratories (ABT)
Κατηγορία
Healthcare
EPS για Abbott Laboratories (ABT)
EPS στις December 2025 TTM: $3.74
Σύμφωνα με τις τελευταίες οικονομικές αναφορές και την τιμή της μετοχής της Abbott Laboratories, το τρέχον EPS της εταιρείας (TTM) είναι $3.74. Στο τέλος του 2026, η εταιρεία είχε EPS 0, ίσο με το EPS του 2026 που ήταν 0.
Ιστορικό EPS της Abbott Laboratories από 2026 έως 2026
EPS στο τέλος κάθε έτους
| Έτος | EPS | Αλλαγή |
|---|---|---|
| Δεν υπάρχουν αρκετά δεδομένα για τις παρεχόμενες ημερομηνίες. | ||
EPS για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | EPS | Διαφορά EPS | Χώρα |
|---|---|---|---|
| $3.59 | -4.01% |
IE
|
|
| $9.73 | 160.16% |
US
|
|
| $2.48 | -33.69% |
US
|
|
| - | - |
DE
|
|
| $1.74 | -53.48% |
US
|
